全文获取类型
收费全文 | 15203篇 |
免费 | 1036篇 |
国内免费 | 223篇 |
专业分类
耳鼻咽喉 | 220篇 |
儿科学 | 345篇 |
妇产科学 | 738篇 |
基础医学 | 1934篇 |
口腔科学 | 275篇 |
临床医学 | 1613篇 |
内科学 | 3210篇 |
皮肤病学 | 375篇 |
神经病学 | 929篇 |
特种医学 | 561篇 |
外科学 | 2334篇 |
综合类 | 434篇 |
现状与发展 | 2篇 |
一般理论 | 3篇 |
预防医学 | 721篇 |
眼科学 | 287篇 |
药学 | 1105篇 |
中国医学 | 108篇 |
肿瘤学 | 1268篇 |
出版年
2023年 | 69篇 |
2022年 | 53篇 |
2021年 | 370篇 |
2020年 | 225篇 |
2019年 | 330篇 |
2018年 | 427篇 |
2017年 | 292篇 |
2016年 | 296篇 |
2015年 | 469篇 |
2014年 | 598篇 |
2013年 | 754篇 |
2012年 | 1116篇 |
2011年 | 1099篇 |
2010年 | 726篇 |
2009年 | 590篇 |
2008年 | 882篇 |
2007年 | 917篇 |
2006年 | 814篇 |
2005年 | 833篇 |
2004年 | 706篇 |
2003年 | 583篇 |
2002年 | 544篇 |
2001年 | 471篇 |
2000年 | 415篇 |
1999年 | 349篇 |
1998年 | 135篇 |
1997年 | 96篇 |
1996年 | 84篇 |
1995年 | 77篇 |
1994年 | 80篇 |
1993年 | 56篇 |
1992年 | 180篇 |
1991年 | 177篇 |
1990年 | 149篇 |
1989年 | 130篇 |
1988年 | 120篇 |
1987年 | 128篇 |
1986年 | 113篇 |
1985年 | 91篇 |
1984年 | 82篇 |
1983年 | 71篇 |
1980年 | 47篇 |
1979年 | 60篇 |
1978年 | 53篇 |
1977年 | 44篇 |
1976年 | 46篇 |
1975年 | 41篇 |
1974年 | 47篇 |
1972年 | 61篇 |
1971年 | 37篇 |
排序方式: 共有10000条查询结果,搜索用时 156 毫秒
41.
42.
43.
44.
Chang-Han Lo Yu-Juei Hsu Shun-Neng Hsu Chin Lin Sui-Lung Su 《Singapore medical journal》2020,61(11):605
INTRODUCTIONNontraumatic acute abdomen (NTAA) in dialysis patients is a challenging issue. The aetiologies of NTAA vary considerably depending on the renal replacement therapy (RRT) modality. Although haematological parameters and contributing factors have been reported to be associated with outcomes for dialysis patients, their clinical effect on the length of hospital stay (LOS) remains unknown.METHODSWe retrospectively analysed 52 dialysis patients (peritoneal dialysis [PD], n = 33; haemodialysis [HD], n = 19) and 30 non-dialysis patients (as controls) between January 2011 and December 2014. To attenuate the selection bias, non-dialysis patients with NTAA were matched to cases at a ratio of 1:1 by age, gender and comorbidities (diabetes mellitus and hypertension). Their demographic characteristics, laboratory data, clinical assessment scores and LOS were analysed.RESULTSThe PD group exhibited a significantly higher neutrophil percentage, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR); longer LOS; and lower lymphocyte percentage and absolute lymphocyte count than the control group. After multivariate analysis adjustment, female gender, longer RRT duration and higher intact parathyroid hormone (iPTH) levels were associated with a lower probability of being discharged home. In the dialysis group, a higher iPTH level (> 313 μg/mL) was positively correlated with longer LOS. iPTH level combined with NLR can be used as a surrogate marker for predicting longer LOS (p < 0.001).CONCLUSIONNTAA dialysis patients with female gender, longer RRT duration and higher iPTH levels are prone to experiencing longer LOS. In addition, the combination of iPTH and NLR is a significant determinant for LOS in NTAA dialysis patients. 相似文献
45.
46.
Thomas W. Lycan DO MHS Fang-Chi Hsu PhD Christine S. Ahn MD Alexandra Thomas MD Francis O. Walker MD Omar P. Sangueza MD Yusuke Shiozawa MD PhD Sun Hee Park PhD Christopher M. Peters PhD Edgar Alfonso Romero-Sandoval MD Susan A. Melin MD Steven Sorscher MD Katherine Ansley MD Glenn J. Lesser MD Michael S. Cartwright MD Roy E. Strowd MD 《Muscle & nerve》2020,61(5):587-594
47.
Phung‐Anh Nguyen Chih‐Cheng Chang Cooper J. Galvin Yao‐Chin Wang Soo Yeon An Chih‐Wei Huang Yu‐Hsiang Wang Min‐Huei Hsu Yu‐Chuan Li Hsuan‐Chia Yang 《Cancer science》2020,111(8):2965-2973
Statins have been shown to be a beneficial treatment as chemotherapy and target therapy for lung cancer. This study aimed to investigate the effectiveness of statins in combination with epidermal growth factor receptor‐tyrosine kinase inhibitor therapy for the resistance and mortality of lung cancer patients. A population‐based cohort study was conducted using the Taiwan Cancer Registry database. From January 1, 2007, to December 31, 2012, in total 792 non‐statins and 41 statins users who had undergone EGFR‐TKIs treatment were included in this study. All patients were monitored until the event of death or when changed to another therapy. Kaplan‐Meier estimators and Cox proportional hazards regression models were used to calculate overall survival. We found that the mortality was significantly lower in patients in the statins group compared with patients in the non‐statins group (4‐y cumulative mortality, 77.3%; 95% confidence interval (CI), 36.6%‐81.4% vs. 85.5%; 95% CI, 78.5%‐98%; P = .004). Statin use was associated with a reduced risk of death in patients the group who had tumor sizes <3 cm (hazard ratio [HR], 0.51, 95% CI, 0.29‐0.89) and for patients in the group who had CCI scores <3 (HR, 0.6; 95% CI, 0.41‐0.88; P = .009). In our study, statins were found to be associated with prolonged survival time in patients with lung cancer who were treated with EGFR‐TKIs and played a synergistic anticancer role. 相似文献
48.
49.
Po-Han Lin Yen-Ting Tung Hsin-Yuan Chen Yi-Fen Chiang Hui-Chih Hong Ko-Chieh Huang Sung-Po Hsu Tsui-Chin Huang Shih-Min Hsia 《Journal of pineal research》2020,68(1):e12620
The circadian nature of melatonin has a protective effect on the progression of female reproductive cancers, including breast and ovarian cancers. However, the effect of melatonin on the growth of uterine leiomyoma is still unclear. In this study, we found that the growth of uterine leiomyoma ELT3 cells was reduced by treatment with melatonin. Treatment with melatonin increased the distribution of sub-G1 phase and increased DNA condensation in ELT3 cells. Melatonin-induced apoptosis and autophagy cell death progression were observed in ELT3 cells. Melatonin exerts a highly selective effect on primary normal human uterine smooth muscle (UtSMC) cells. The UtSMC cell cycle was arrested by melatonin treatment through up-regulation of p21, p27, and PTEN protein expression, but melatonin did not further promote apoptosis program activation. Melatonin reduced cell proliferation in ELT3 cells underlying the activation of melatonin MT1 and MT2 receptors, which in turn down-regulated the Akt-ERK1/2-NFκB signaling pathway. Melatonin reduced ELT3 tumor growth in both xenograft and orthotopic uterine tumor mice models. The extracellular matrix of the tumor was also reduced by melatonin treatment. Taken together, these results suggest that melatonin potentially plays a role in suppression of uterine leiomyoma growth. 相似文献
50.
Ping-Tao Tseng Chun-Pai Yang Kuan-Pin Su Tien-Yu Chen Yi-Cheng Wu Yu-Kang Tu Pao-Yen Lin Brendon Stubbs Andre F. Carvalho Yutaka J. Matsuoka Dian-Jeng Li Chih-Sung Liang Chih-Wei Hsu Yen-Wen Chen Yow-Ling Shiue 《Journal of pineal research》2020,69(2):e12663
Although exogenous melatonin supplementation has been suggested to be effective for episodic migraine prophylaxis, there is no conclusive evidence comparing the efficacy of exogenous melatonin supplementation to the other FDA-approved pharmacotherapy for episodic migraine prophylaxis. The aim of the current network meta-analysis (NMA) was to compare the efficacy of exogenous melatonin supplementation in patients with episodic migraine. The randomized placebo-controlled trials or randomized controlled trials (RCTs) incorporating a placebo in the study designs were included in our analyses. All of the NMA procedures were conducted under the frequentist model. The primary outcome was changes in frequency of migraine days and response rate after migraine prophylaxis with melatonin supplementation or pharmacological interventions. We included 25 RCTs in total with 4499 patients (mean age = 36.0 years, mean female proportion = 78.9%). The NMA demonstrated that migraine prophylaxis with oral melatonin 3 mg/d (immediate-release) at bedtime was associated with the greatest improvement in migraine frequency [mean difference = −1.71 days, 95% confidence interval (CI): −3.27 to −0.14 days compared to placebo] and the second highest response rate (odds ratio = 4.19, 95% CI = 1.46 to 12.00 compared to placebo). Furthermore, oral melatonin 3 mg (immediate-release) at bedtime was the most preferred pharmacological intervention among all of the investigated interventions when improvements in migraine frequency, response rate, dropout rate, and rates of any adverse events were taken into account. This pilot NMA suggests the potential prophylactic role of exogenous melatonin supplementation in patients with episodic migraine. 相似文献